ReviewFrontiers in bioengineering and biotechnology2026
Nanostructured surfaces for enveloped virus inactivation: mechanisms and fabrication strategies.
Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enveloped viruses, owing to the intrinsic sensitivity of their lipid envelopes to physical perturbations, have attracted increasing attention in the field of antiviral surface engineering. Compared with conventional chemical-based strategies, nanostructured surfaces can inactivate viruses through interfacial physical interactions without the need for continuous external stimuli. This review summarizes the primary mechanisms underlying nanostructure-induced viral inactivation, including mechanical piercing, stretching-induced rupture, and array-induced synergistic effects. Among these, membrane stretching and localized stress concentration arising from multivalent contact are identified as the dominant mechanisms. Key factors influencing antiviral performance, such as structural spacing, tip geometry, and virus size, are further discussed. In addition, common fabrication approaches, including etching, template-assisted replication, and plasma-based techniques, are reviewed. The contributions of surface composition to antiviral performance are also highlighted, with emphasis on the synergistic effects between nanostructured features and functional materials. Finally, current challenges related to mechanistic understanding, structure-activity relationships, and practical implementation are highlighted, providing insights for the rational design of antiviral surfaces.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.